Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Gold/Mining/Energy : Position Trading in Canada -- Ignore unavailable to you. Want to Upgrade?

To: Essam Hamza who wrote (171)	12/16/1998 12:54:00 AM
From: keith massey	Read Replies (2) \| Respond to of 2259

Hey Essam Good reason for using a full service. I am notified about ipos through friends that pay for full service and don't transfer shares so I am fairly happy in the discount world. Priorities announced new rates when using PCQuotes. They were attach to the news release announcing the combo. With Priority each trade cost you a percentage of the trade dollar value. When trading higher priced stocks this percentage method would normally double the commission I pay with E-trade. However for lower priced stocks Priority seems like the way to go. Although PFE is an American stock I will comment on it. From a technical standpoint PFE is looking very weak. It just ran up 25% on decreasing volume and momentum is slowing. I am assuming that you are referring to Celebrex as the new drug. Funny thing is that I just read a paper on COX-2 inhibitors (I think in Inflamation Research) last month. Was looking at COX isoenzymes play in delayed onset muscle soreness. Smart guys using this instead of NSAIDs. I don't know if it will be bigger than Viagra since a lot of doctors will stick with NSAID for several years before (if) they switch over. Other than stomach pains there isn't a lot of side effects with NSAIDs. Hard to say how this drug will effect the stock in the long term. However in the short term the chart looks a little scary for me. Best Regards KEITH